Featured, News, Trade Ideas

Telomir Pharmaceuticals Breakthrough in Silver-Based Medicine

February 20, 2025 No comments yet

Telomir Pharmaceuticals (NASDAQ: TELO) has achieved a major scientific breakthrough by stabilizing Silver(II) (Ag²⁺) using its proprietary compound, Telomir-1. This advancement overcomes a key challenge in silver-based medicine, unlocking new possibilities for antimicrobial treatments, wound care, and infection-resistant medical coatings. Silver(II) offers superior antibacterial action, faster wound healing, and immune-modulating properties compared to traditional Silver(I) […]

Featured, News, Trade Ideas

Telomir Pharmaceuticals Advances Copper-Binding Research with Telomir-1

December 23, 2024 No comments yet

Telomir Pharmaceuticals (TELO), a trailblazer in age-reversal research, has announced groundbreaking results demonstrating Telomir-1’s exceptional copper-binding properties. This advancement bolsters the compound’s potential to treat Wilson’s disease, a rare genetic disorder caused by toxic copper accumulation. The findings also expand Telomir’s focus on developing innovative therapies for critical medical challenges. Copper Regulation and Wilson’s Disease […]